non-small cell lung cancer

Merck’s KEYTRUDA® (pembrolizumab) Approved by the European Commission for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1
Yahoo
Wed, 08/3/16 - 09:02 am
Merck
Keytruda
Europe
non-small cell lung cancer
AstraZeneca phase 3 trial confirms Tagrisso's efficacy
BioPharma Dive
Tue, 07/19/16 - 09:53 am
AstraZeneca
clinical trials
Tagrisso
non-small cell lung cancer
Ariad Taking The Fast Track Into Lung Cancer Treatment
Seeking Alpha
Mon, 06/20/16 - 10:14 am
Ariad Pharmaceuticals
fast track
non-small cell lung cancer
Ponatinib
Merck Extends Cancer Immunotherapy Reach to First-Line Lung Cancer
TheStreet.com
Thu, 06/16/16 - 09:57 am
Merck
Keytruda
non-small cell lung cancer
Drug makers pay $67m for misleading docs about cancer drug survival data
Stat
Mon, 06/6/16 - 11:21 pm
Roche
Genentech
OSI Pharmaceuticals
False Claims Act
whistleblower lawsuits
Tarceva
non-small cell lung cancer
AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
Forbes
Sun, 06/5/16 - 11:50 am
AbbVie
Rova-T
non-small cell lung cancer
ASCO 2016
Daiichi Sankyo halts late-stage study of lung cancer drug
BioPharma Dive
Wed, 06/1/16 - 04:47 pm
Daiichi Sankyo
clinical trials
non-small cell lung cancer
patritumab
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
FDA staff questions Clovis drug's benefit over current treatments
Yahoo/Reuters
Fri, 04/8/16 - 11:08 am
FDA
Clovis Oncology
rociletinib
non-small cell lung cancer
What Latest Xalkori Approval Means for Pfizer
Bidness, ETC
Mon, 03/14/16 - 10:05 am
Pfizer
Xalkori
FDA
non-small cell lung cancer
Keytruda: Merck’s New Blockbuster for Its Immuno-Oncology Franchise
Yahoo/Market Realist
Sun, 03/6/16 - 11:33 am
Keytruda
Merck
immuno-oncology
melanoma
non-small cell lung cancer
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
BioPharma Dive
Fri, 02/26/16 - 09:34 am
Eli Lilly
Portrazza
Europe
biologics
non-small cell lung cancer
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Yahoo/Benzinga
Fri, 02/12/16 - 04:25 pm
Clovis Oncology
rociletinib
FDA
non-small cell lung cancer
This Lung Cancer Drug May Not Be What It Seems, Chemists Say
Forbes
Fri, 01/1/16 - 11:50 am
non-small cell lung cancer
antroquinonol
Taiwan
Golden Biotechnology Corporation
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Boehringer Ingelheim
breakthrough therapies
BI1482694
AstraZeneca
Clovis Oncology
non-small cell lung cancer
Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Fierce Pharma
Mon, 12/14/15 - 04:15 pm
drug pricing
Portrazza
Eli Lilly
non-small cell lung cancer
It's official: FDA shoots past 2014's new drugs record with Roche lung cancer med nod
BioPharma Dive
Mon, 12/14/15 - 11:03 am
FDA
Roche
Genentech
non-small cell lung cancer
Alecensa
drug approvals
Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Yahoo
Tue, 12/8/15 - 11:24 am
Pfizer
FDA
Xalkori
non-small cell lung cancer
Clovis Oncology's Loss Could Be a Win for AstraZeneca
Motley Fool
Thu, 11/19/15 - 09:47 am
Clovis Oncology
AstraZeneca
rociletinib
Tagrisso
non-small cell lung cancer
In major victory, AstraZeneca wins FDA approval for potential $3B lung cancer med
BioPharma Dive
Mon, 11/16/15 - 11:54 am
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer

Pages